Literature DB >> 23890240

Antimicrobials, susceptibility testing, and minimum inhibitory concentrations (MIC) in veterinary infection treatment.

Mark G Papich1.   

Abstract

Veterinarians are quick to attribute an unsuccessful antimicrobial treatment to a failure of the culture and susceptibility test. There are many reasons why antimicrobial treatment fails. When evaluating a patient that has failed to respond to therapy, one must consider any of the many factors that contribute to antibiotic failure.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobials; Minimum inhibitory concentration; Susceptibility testing; Veterinary infection treatment

Mesh：

Substances：

Year:  2013        PMID： 23890240     DOI： 10.1016/j.cvsm.2013.04.005

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN： 0195-5616            Impact factor:   2.093


  10 in total

1.  Cumulative antibiogram and multidrug-resistant organisms in a regional equine referral hospital.

Authors:  Ka Y Yuen; Justine S Gibson; Sophia Hinrichsen; Carlos E Medina-Torres; Francois-Rene Bertin; Allison J Stewart
Journal:  J Vet Diagn Invest       Date:  2020-11-28       Impact factor: 1.279

2.  Plasma Peak and Trough Gentamicin Concentrations in Hospitalized Horses Receiving Intravenously Administered Gentamicin.

Authors:  J R Bauquier; R C Boston; R W Sweeney; P A Wilkins; R D Nolen-Walston
Journal:  J Vet Intern Med       Date:  2015-10-01       Impact factor: 3.333

3.  What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?

Authors:  L Dorey; S Hobson; P Lees
Journal:  J Vet Pharmacol Ther       Date:  2017-01-18       Impact factor: 1.786

4.  Genetic resistance determinants to fusidic acid and chlorhexidine in variably susceptible staphylococci from dogs.

Authors:  S-M Frosini; R Bond; M Rantala; T Grönthal; S C Rankin; K O'Shea; D Timofte; V Schmidt; J Lindsay; A Loeffler
Journal:  BMC Microbiol       Date:  2019-04-25       Impact factor: 3.605

5.  Genotypic antimicrobial resistance characterization of E. coli from dairy calves at high risk of respiratory disease administered enrofloxacin or tulathromycin.

Authors:  R V Pereira; C Foditsch; J D Siler; S C Dulièpre; C Altier; A Garzon; L D Warnick
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

6.  Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers.

Authors:  Jeffrey J Sarchet; John P Pollreisz; David T Bechtol; Mitchell R Blanding; Roger L Saltman; Patrick C Taube
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

7.  Milk microbial composition of Brazilian dairy cows entering the dry period and genomic comparison between Staphylococcus aureus strains susceptible to the bacteriophage vB_SauM-UFV_DC4.

Authors:  Vinícius da Silva Duarte; Laura Treu; Cristina Sartori; Roberto Sousa Dias; Isabela da Silva Paes; Marcella Silva Vieira; Gabriele Rocha Santana; Marcos Inácio Marcondes; Alessio Giacomini; Viviana Corich; Stefano Campanaro; Cynthia Canedo da Silva; Sérgio Oliveira de Paula
Journal:  Sci Rep       Date:  2020-03-26       Impact factor: 4.379

8.  Evaluation of urine concentrations of amoxicillin and clavulanate in cats.

Authors:  Kate KuKanich; Kallie Woodruff; Zackery Bieberly; Mark G Papich; Butch KuKanich
Journal:  J Vet Intern Med       Date:  2020-12-06       Impact factor: 3.175

9.  Escherichia coli-associated granulomatous colitis in dogs treated according to antimicrobial susceptibility profiling.

Authors:  Alison C Manchester; Belgin Dogan; Yongli Guo; Kenneth W Simpson
Journal:  J Vet Intern Med       Date:  2020-12-15       Impact factor: 3.175

10.  Alternative and Complementary Therapies against Foodborne Salmonella Infections.

Authors:  Mohamed F Ghaly; Zahraa M Nasr; Amira I Abousaty; Hanan G Seadawy; Mohamed A A Shaheen; Sarah Albogami; Mohammad M Al-Sanea; Mahmoud M Bendary
Journal:  Antibiotics (Basel)       Date:  2021-11-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.